PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
29-Apr-2021 Cambridge Research Biochemicals signs distribution deal with Fluoroprobes, LLC Cambridge Research Biochemicals
29-Apr-2021 APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share APONTIS PHARMA AG
29-Apr-2021 Cambridge Research Biochemicals signs distribution deal with Fluoroprobes, LLC Sciad Newswire
29-Apr-2021 Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2021 Heidelberg Pharma AG
28-Apr-2021 Invitation to MorphoSys' First Quarter Results Conference Call on May 6, 2021 MorphoSys AG
28-Apr-2021 IGEA announces extraordinary general meeting results IGEA Pharma N.V.
28-Apr-2021 Vetter and Rentschler Biopharma Further Strengthen their Strategic Alliance Vetter
28-Apr-2021 Toxys and Unilever Enter Agreement to Further Validate and Expand ReproTracker® for Animal-Free Developmental Toxicity Assessment Toxys
28-Apr-2021 Vetter and Rentschler Biopharma Further Strengthen their Strategic Alliance B3C newswire
28-Apr-2021 Vertex Announces European Commission Approval for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat Cystic Fibrosis Patients 12 Years and Older With At Least One F508del Mutation in the CFTR gene Vertex
28-Apr-2021 CytoSMART redefines automated cell counting with a new fluorescence cell counter CytoSMART
28-Apr-2021 Isohelix and AutoGen sign a collaborative supply agreement Isohelix
28-Apr-2021 Toxys and Unilever Enter Agreement to Further Validate and Expand ReproTracker® for Animal-Free Developmental Toxicity Assessment B3C newswire
28-Apr-2021 Eckert & Ziegler Signs Long-Term Supply Agreement with Sirtex Medical on Yttrium-90 for Treating Liver Cancer Eckert & Ziegler Strahlen- und Medizintechnik AG
28-Apr-2021 GenNext Technologies Announces NIH Grant Funding of Nearly $7M Leads to a Seminal Protein Footprinting Patent GenNext Technologies
28-Apr-2021 Transgene reports business update and end Q1 2021 financial position Transgene
28-Apr-2021 Advanced Biological Laboratories Receives CE-IVD Registration for its UltraGene SARS-CoV-2 Triplex Assay Advanced Biological Laboratories (ABL)
28-Apr-2021 Santhera and ReveraGen Announce New 2.5-year Treatment Data with Vamorolone in Duchenne Muscular Dystrophy Santhera
28-Apr-2021 First patient enrolled in CARE-HK in HF to evaluate role of Veltassa® (patiromer) in enabling RAASi treatment Vifor Pharma
28-Apr-2021 FDA grants priority review for Nefecon, for patients with IgA nephropathy Calliditas Therapeutics AB